Organigram Global (OGI) Total Non-Current Liabilities (2019 - 2026)

Organigram Global (OGI) posted quarterly Total Non-Current Liabilities of $107.9 million for Q1 2026, down 2.85% on a QoQ basis from $111.1 million in Q4 2025.

Organigram Global (OGI) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Total Non-Current Liabilities for 6 consecutive years, with $107.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Non-Current Liabilities changed N/A year-over-year to $107.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.9 million (changed N/A YoY) and the FY2025 annual result came in at $111.1 million, changed N/A from the prior year.
  • Total Non-Current Liabilities fell to $107.9 million in Q1 2026 per OGI's latest filing, from $111.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for OGI reached as high as $149.0 million in Q3 2025 and fell as low as $72.2 million in Q3 2024.
  • A 3-year average of $110.1 million and a median of $109.5 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • The largest YoY upside for Total Non-Current Liabilities was 106.3% in 2025 against a maximum downside of 106.3% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $72.2 million in 2024, then soared by 53.88% to $111.1 million in 2025, then dropped by 2.85% to $107.9 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $107.9 million, $111.1 million, and $149.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn 107.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 107.95 Mn
Dec 31, 2025 111.11 Mn
Sep 30, 2025 148.96 Mn
Sep 30, 2024 72.21 Mn
Nov 30, 2021 -8.22 Mn
Aug 31, 2021 49.51 Mn
May 31, 2021 -9.20 Mn
Feb 28, 2021 120.87 Mn
Nov 30, 2020 150.00 Mn
Aug 31, 2020 98.06 Mn
May 31, 2020 78.98 Mn
Feb 29, 2020 121.85 Mn
Aug 31, 2019 75.94 Mn